A prospective observational study of drug usage in the management of snake bite patients and their outcome in a tertiary care teaching hospital


  • Supriya Kumari Hirebail Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
  • Nagabushan H. Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
  • Prakash G. M. Department Medicine, Mandya Institute of Medical Sciences, Mandya, Karnataka, India




Anti-snake venom, Morbidity, Viper


Background: The objectives of the study were to assess the pattern of management of snakebite especially with respect to use of anti- snake venom and other supportive treatment given and to assess the effect of anti-snake venom on different types of snakebite and to assess their outcome.

Methods: A prospective observational study was conducted over a period of 6 months, after getting approval from Institutional Ethics committee. Total of 144 snake bite patients were analysed for six months duration for use of anti-snake venom and other supportive treatment in their management and were assessed for their outcome like recovery, morbidity and mortality.

Results: Out of 144 snake bite patients analysed, 71.5% had poisonous type and 28.4% had non- poisonous type of snake bite. Among the total number of snakebites, 47.2% were unknown type and among the known type 25% were viper, 13.2% cobra, 7.6% krait, 6.3% sea snake and 0.7% green snake. Anti-snake venom (ASV) was given to 62 patients depending on severity, of which, 22 patients developed reaction to ASV. Patient with reaction to ASV were treated with corticosteroid and antihistamine injection. Morbidity was seen in 29.1% of patients who developed either cellulitis or gangrene of bitten area, which was more commonly seen among viper bite patients (54.7%).

Conclusions: Snakebite is one of the commonest tropical diseases leading to envenomation and poisoning especially in rural areas of tropical countries which has to be treated as early as possible to prevent complications. Majority of the cases in our study were of viper bite and most of them have recovered after treatment.

Author Biography

Supriya Kumari Hirebail, Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India




Emilie A, Sanjib K, Himmatrao SB, Ulrich K, Francois C. Snakebite in South Asia: A Review. PLoS Negl Trop Dis. 2010;4(1):1-9.

Gupta YK, Peshin SS. Snake bite in India: Current scenario of old problem. J Clin Toxicol. 2014;4(1):1-9.

Bawaskar HS, Bawaskar PH. Snakebite poisoning. Journal of Mahatma Gandhi Institute of Med Sciences. 2015;20(1):5-14.

Priyanka KG, Mayuri S, Rashmi SS. Snake venom, anti-snake venom & potential of snake venom. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6(5):4-7.

Paul V, Prathibha S, Pralhad KA, Jerry E, Francis S, Francis L. High dose Anti Snake Venom versus low dose antisnake venom in the treatment of poisonous snakebites- A critical study. JAPI. 2004;52:14-7.

Farrar J, Hotez PJ, Junghan T, Keng G, Lalloo D, White N. Manson’s Tropical diseases. 22nd ed. China: Saunders Elsevier; 2009:557-601.

Syed MA, Mohib A, Abu N, Jyotsna M, Adarash C, Jyotishka P. Emergency treatment of a snake bite: Pearls from literature. J Emerg Trauma Shock. 2008;1(2):97-105.

Gregory J, John GH. Venomous snakebites in US: Management Review and update. American Family Physician. 2002;65:1367-74.

Senaviratne SL, Opanayaka CJ, Ratnayake NS, Kumara KS, Sugathadasa AM, Weerasuriya N, et al. Use of antivenom serum in snake bite: a prospective study of hospital practice in the Gampaha district. Ceylon Medical Journal. 2015 Jan 26;45(2).

Vinod SD, Vijay MM, Dharmendra G, Birajdar SV, Rushikesh D, Harshal P, et al. Study on acute adverse drug reactions of antisnake venom in a rural tertiary care hospital. Asian J Pharm Clin Res. 2014;7(5):13-5.

Shraddha MP, Sunita JR, Praveenkumar TP, Alka DG, Mayur PP, Smita LG, et al. A retrospective study of use of polyvalent antisnake venom and risk factors for mortality from snakebite in a tertiary care setting. Indian J of Pharmacol. 2015;47(3):270-74.

Rushikesh PD, Vijay MM, Sudhir LP, Rakesh RP, Chetanraj GB, Vinod SD, et al. Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital. Journal of Young Pharmacists. 2013;5:41-5.

Himmatrao SB, Pramodini HB. Envenoming by the common krait (Bungarus caeruleus) and Asian cobra (Naja naja): Clinical manifestations and their management in a rural setting. Wilderness and environmental Medicine. 2004;15:257-66.

Damien P, Frank B, Josephat N, Aaron H, Yvonne B, Stephan B, et al. Presentation, management and outcome of snakebites in two district hospitals in Ghana. Pan African Medical Journal. 2014;19:1-9.

Amin MR, Mamun SMH, Rashid R, Rahman M, Ghose A, Sharmin S, et al. Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh. J. Venom. Anim. Toxins incl. Trop. Dis. 2008;14(4):660-72.

Punde DP. Management of snakebite in rural Maharashtra: A 10 year experience. National Medical Journal of India. 2005;18:71-5.

Virendra CP, Harsha VP, Avinash P, Vaibhav A. Clinical Profile and outcome of envenomous snake-bite at tertiary care centre in western Maharashtra. Int. J. Med. Public health. 2011;1(4):28-38.

Punam AG, Jugalkishore BJ, Ganesh RP, Shrikant CD, Vishal MU, Sonal MP. A study on the clinico-epidemiological profile and the outcome of snake bite cases in the tertiary care hospital. International J of Basic & Clinical Pharmacology. 2014;3(2):298-302.

Asita DH, Arunasalam P, Channa DR, Shaluka J, Senarath BS, Ariyasena H et al. Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial. PLoS Medicine Open Access Journal. 2011;8(5):1-9.

Guillermo L, María H, Álvaro S, Mauren V, Mariángela V, José MG. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon. 2013:63-76.

Chauhan S, Faruqi S, Bhalla A, Sharma N, Varma S, Bali J. Pre-hospital treatment of snake envenomation in patients presented at a tertiary care hospital in North-western India. J. Venom. Anim. Toxins incl. Trop. Dis. 2005;11:275-82.

Monteiro FNP, Kanchan T, Bhagavath P, Kumar GP, Menezes RG, Yoganarasimha K. Clinico-epidemiological features of viper bite envenomation: a study from Manipal, South India. Singapore Med J. 2012;53(3):204-7.

Robert AH, Darren AC, Camila R, Nicholas RC, Rachel BC, Simon CW. Research strategies to improve snakebite treatment: Challenges and progress. Journal of Proteomics. 2011:1768-80.

Sakthivel V, Rajendran V, Rajesh A, Karthikeyan R, Kameshwaran N, Anburaj J, et al. Snakebite and Its Socio-Economic Impact on the Rural Population of Tamil Nadu, India. PLoS ONE 8(11): e80090. 2013;8(11):1-9.




How to Cite

Hirebail, S. K., H., N., & G. M., P. (2017). A prospective observational study of drug usage in the management of snake bite patients and their outcome in a tertiary care teaching hospital. International Journal of Basic & Clinical Pharmacology, 6(12), 2836–2842. https://doi.org/10.18203/2319-2003.ijbcp20175204



Original Research Articles